CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,725 shares at $1.70 ($2,933)
- 4 Open-market sale Director sold 20,000 shares at $1.79 ($35,700)
- 4 Planned sale Chief Legal Officer sold 16,667 shares at $1.71 ($28,501)
- 4 Planned sale Chief Financial Officer sold 82,657 shares at an average $2.16 ($178,745)
- 4 Planned sale Chief Legal Officer sold 16,667 shares at $2.07 ($34,417)
- 4 Planned sale Chief Medical Officer sold 21,605 shares at $2.50 ($54,013)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Open-market buy Director bought 2,500 shares at $1.99 ($4,975)
- 4 Open-market buy Director bought 2,000 shares at $1.79 ($3,578)
Page 4 of 36 · 701 filings